Cesium Therapy in Cancer Patients Life Science University Medical Center, Suite 306, 4501 Connecticut Ave.,
Washingon, DC, 20008.
Cesium Therapy in Cancer Patients
Certain foods contain biologically active compounds and/or ingredients, i.e., vitamins, inorganic salts,
organic compounds, essential fatty acids, minerals, and chelating agents which may either precipitate
or prevent cancer development. The relationship between dietary consumption and cancer development
is not clear and further investigation continues.
Noteworthy is the report on the presence of high levels of Cesium (Cs) and rubidium (Rb) in food along
with availability of various supportive compounds as vitamins A and C, along with zinc and selenium in
diets of populations residing in areas with low incidence of cancer, e.g., the Hopi Indian territory in Arizona,
the Hunza area in North Pakistan, and the volcanic regions of Brazil. The diet of these populations is similar
to the nutritive requirements for the high pH cancer therapy developed by Brewer subsequent series of
physical experiments with cancer cells.
In these tests the presence of Cs+ or Rb+ in the adjacent fluids of the tumor cell is believed to raise the pH
of the cancer cell where cell mitosis will cease resulting in reduction of life span of the cancer cell. The
introduction of such alkaline pH by these alkali salts may also neutralize the acidic and toxic material within
the cancer cell. This report combines the use of CsCl with various supportive agents, which have been
hypothesized both to enhance the entry of Cs+ into the cancer cell and to stimulate the immune response,
in the treatment of various cancers.
METHOD
Treatment was performed on 50 patients during the last three years at Life Science Universal Medical
Center Clinics in Rockville, MD and in Washington, DC. All patients were terminal subjects with generalized
metastatic disease. Forty-seven of the fifty patients studied had received maximal modalities of treatment,
i.e., surgery, radiation and various chemotherapy, before the metabolic Cs-treatment was initiated. Three
patients were comatose and 14 of the patients were considered terminal due to previous treatments
outcome and cancer complications.
The Cs-treatment was given in conjunction with other supportive compounds and under diet control in
addition to utilization of specific compounds to produce adequate circulation and oxygenation. According
to individual cases CsCl was given at daily dosages of 6 to 9 g. in three equally divided doses with vitamin
A-emulsion (100,000 to 300,000 U), vitamin C (4 to 30g), zinc (80 to 100 mg), selenium (600 to 1,200 mcg)
and amygdalin (1500 mg) in addition to other supplementations according to the specific needs of the
patient.
The diet consisted mainly of whole grains, vegetables, linolenic acid rich oils (linseed, walnut, soy, wheat
germ) and other supplemental food. To increase efficiency of the treatment and improve the circulation
and oxygenation, the patients received the chelating agent EDTA, dimethylsulfoxide (DMSO) and also a
combination of vitamin K and Mg salts.
RESULTS
The percent of survival of breast, colon, prostate, pancreas and lung cancer accounted to approximately
50% which was higher than noted for liver cancer and the lymphoma patients treated.
An overall 50% recovery from cancer by the Cs. therapy was determined in the fifty patients treated. Data
from the autopsy indicated the absence of tumors in patients dying within fourteen days of the Cs-treatment.
One of the most striking effects of the treatment was the disappearance of pain in all patients within one to
three days after initiation of the Cs-therapy.
| Cesium therapy in cancer patients excerpted from annieappleseed.project.org |
 | |  | |  | |  | |  | |  | |  | |  |